GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (NAS:RDHL) » Definitions » Change In Prepaid Assets

RDHL (Redhill Biopharma) Change In Prepaid Assets : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Redhill Biopharma Change In Prepaid Assets?

Redhill Biopharma's Change In Prepaid Assets for the quarter that ended in Dec. 2024 was $0.00 Mil. It means Redhill Biopharma's Prepaid Assets stayed the same from Jun. 2024 to Dec. 2024 .

Redhill Biopharma's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was $1.70 Mil. It means Redhill Biopharma's Prepaid Assets increased by $1.70 Mil from Dec. 2023 to Dec. 2024 .


Redhill Biopharma Change In Prepaid Assets Historical Data

The historical data trend for Redhill Biopharma's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Change In Prepaid Assets Chart

Redhill Biopharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.28 0.86 0.27 1.59 1.70

Redhill Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 2.12 - - -

Redhill Biopharma Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Redhill Biopharma Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Redhill Biopharma Business Description

Traded in Other Exchanges
N/A
Address
21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.